Kangmei Pharma | 600518 - Gross Profit On Sales

Stock Price
1.59
Daily Change
-0.02 -1.24%
Monthly
-9.14%
Yearly
-20.90%
Q2 Forecast
1.59

Kangmei Pharma reported CNY270.29M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Genomma Lab Internacional MXN 2.66B 208.35M Mar/2026
Hypermarcas BRL 1.38B 16.08M Dec/2025
Ionis Pharmaceuticals USD 243M 48M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Moderna USD -566M 792M Mar/2026
Organon & Co USD 854M 3M Dec/2025
Revvity USD 387.66M 34M Mar/2026
Sh Fosun Pharma CNY 6.69B 1.9B Dec/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.38B 229.9M Mar/2026
Wuxi Apptec CNY 6.27B 68.16M Mar/2026
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026